Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Early Pregnancy Failure: Factors Affecting Successful Medical Termination Treatment

This study has been completed.
Information provided by:
Western Galilee Hospital-Nahariya Identifier:
First received: October 28, 2008
Last updated: March 30, 2009
Last verified: March 2009
The main purpose of our study was to which determine factors, those measured by ultrasound and also demographic and clinical factors (age, number of previous pregnancies, abortions and deliveries) predict outcome of medical treatment for early pregnancy failure. Our hypothesis was that gestational sac volume predicts outcome of medical treatment for early pregnancy failure.

Early Pregnancy Failure

Study Type: Observational
Study Design: Time Perspective: Prospective

Resource links provided by NLM:

Further study details as provided by Western Galilee Hospital-Nahariya:

Primary Outcome Measures:
  • An empty uterus or an endometrial lining with thickness of less than 30mm. [ Designated as safety issue: No ]

unsuccessful termination
unsuccessful termination of early pregnancy failure with Misoprostol
successful termination
successful termination of early pregnancy failure with Misoprostol


Ages Eligible for Study:   18 Years to 45 Years   (Adult)
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Women with missed abortion or anembryonic pregnancy, with existing intrauterine pregnancy sac

Inclusion Criteria:

  • Crown rump length (CRL) is appropriate to less than 12 weeks.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00782860

Western Galilee Hospital-Nahariya
Nahariya, Israel, 22100
Sponsors and Collaborators
Western Galilee Hospital-Nahariya
  More Information Identifier: NCT00782860     History of Changes
Other Study ID Numbers: 03-08-2008 
Study First Received: October 28, 2008
Last Updated: March 30, 2009
Health Authority: Israel: Ministry of Health

Keywords provided by Western Galilee Hospital-Nahariya:
Early pregnancy failure
Gestational sac volume

Additional relevant MeSH terms:
Abortifacient Agents, Nonsteroidal
Abortifacient Agents
Reproductive Control Agents
Physiological Effects of Drugs
Anti-Ulcer Agents
Gastrointestinal Agents
Oxytocics processed this record on October 27, 2016